This opinion cites 11 cases:
Yeda Research & Development Co. v. Abbott GmbH & Co. KG , 837 F.3d 1341 ( 2016 )
Graham v. John Deere Co. of Kansas City , 86 S. Ct. 684 ( 1966 )
Alza Corporation v. Mylan Laboratories , 464 F.3d 1286 ( 2006 )
Bristol-Myers Squibb Company v. Teva Pharmaceuticals USA, Inc. , 752 F.3d 967 ( 2014 )
Aventis Pharma Deutschland GmbH v. Lupin, Ltd. , 499 F.3d 1293 ( 2007 )
KSR International Co. v. Teleflex Inc. , 127 S. Ct. 1727 ( 2007 )
Ortho-McNeil Pharmaceutical, Inc. v. Mylan Laboratories, Inc. , 520 F.3d 1358 ( 2008 )
Richard Ruiz and Foundation Anchoring Systems, Inc., Plaintiffs-Cross v. A.B. Chance Company , 234 F.3d 654 ( 2000 )
Pharmasterm Therapeutics, Inc. v. Viacell, Inc. , 491 F.3d 1342 ( 2007 )
In re Oelrich , 666 F.2d 578 ( 1981 )
Eurand, Inc. v. Mylan Pharmaceuticals Inc. , 676 F.3d 1063 ( 2012 )
